RTTNews | Nov 10, 2021 12:04PM EST

12:03 Wednesday, November 10, 2021 (RTTNews.com) - Shares of RenovoRx, Inc. (RNXT) are currently surging nearly 67% on Wednesday morning. RNXT is currently trading at $9.04, up $3.63 or 67.10%, on the Nasdaq.

The biopharmaceutical company on Tuesday announced its novel therapy platform, RenovoTAMPTM, will be highlighted during a presentation by expert panelist, Dr. Ripal Gandhi, at the Miami Cancer Institute's New Advances in the Management of Pancreatic Cancer CME course.

Gandhi, a Principal Investigator in RenovoRx's ongoing Phase 3 TIGeR-PaC study, and Professor of Interventional Radiology at the Miami Cancer Institute and Miami Cardiac and Vascular Institute, Florida International University Herbert Wertheim College of Medicine, will describe the results from initial clinical studies of RenovoTAMP used in combination with radiation therapy and its benefits when managing patients with stage 3 locally advanced pancreatic cancer (LAPC).

Read the original article on RTTNews ( https://www.rttnews.com/3241354/why-is-renovorx-stock-up-67.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved